ViroGates A/S (VIROG)

Currency in DKK
9.52
-0.48(-4.80%)
Closed·
VIROG Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
VIROG is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
9.5210.00
52 wk Range
5.2031.00
Key Statistics
Prev. Close
10
Open
10
Day's Range
9.52-10
52 wk Range
5.2-31
Volume
220
Average Volume (3m)
2.48K
1-Year Change
64.14%
Book Value / Share
0.62
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
VIROG Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock has fared poorly over the last month

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

ViroGates A/S Company Profile

ViroGates A/S, an in vitro diagnostics company, develops and sells blood tests for measuring chronic inflammation for the healthcare sector. It offers suPARnostic, a proprietary biomarker used in hospital clinics to guide and inform individuals of their health state, and in hospitals to support clinical decisions and identify high-risk patients, as well as used for a range of acute and chronic health issues, such as cardiovascular disease, type 2 diabetes, and cancer. The company’s product includes suPARnostic TurbiLatex, a latex particle-enhanced turbidimetric immunoassay that quantitatively determines the soluble urokinase plasminogen activator receptor (suPAR) level in human K2-EDTA- or lithium heparin plasma samples; suPARnostic ELISA that provides fully quantitative results; and suPARnostic Quick Triage kit for use in the point of care situation for early warning and patient triaging that allows clinicians and nurses to obtain a fast patient prognosis for patient disease severity, progression, and outcome. ViroGates A/S was founded in 2000 and is headquartered in Birkerød, Denmark.

Compare VIROG to Peers and Sector

Metrics to compare
VIROG
Peers
Sector
Relationship
P/E Ratio
−5.5x−6.1x−0.5x
PEG Ratio
−0.30−0.280.00
Price/Book
14.7x8.6x2.6x
Price / LTM Sales
7.5x6.8x3.3x
Upside (Analyst Target)
-96.9%38.9%
Fair Value Upside
Unlock6.5%5.4%Unlock

Earnings

Latest Release
Aug 21, 2025
EPS / Forecast
-0.42 / --
Revenue / Forecast
3.67M / --
EPS Revisions
Last 90 days

VIROG Income Statement

FAQ

What Stock Exchange Does ViroGates Trade On?

ViroGates is listed and trades on the Copenhagen Stock Exchange stock exchange.

What Is the Stock Symbol for ViroGates?

The stock symbol for ViroGates is "VIROG."

What Is the ViroGates Market Cap?

As of today, ViroGates market cap is 73.63M.

What Is ViroGates's Earnings Per Share (TTM)?

The ViroGates EPS (TTM) is -1.64.

When Is the Next ViroGates Earnings Date?

ViroGates will release its next earnings report on 05 Nov 2025.

From a Technical Analysis Perspective, Is VIROG a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has ViroGates Stock Split?

ViroGates has split 0 times.

How Many Employees Does ViroGates Have?

ViroGates has 7 employees.

What is the current trading status of ViroGates (VIROG)?

As of 30 Aug 2025, ViroGates (VIROG) is trading at a price of 9.52, with a previous close of 10.00. The stock has fluctuated within a day range of 9.52 to 10.00, while its 52-week range spans from 5.20 to 31.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.